Access the full text.
Sign up today, get DeepDyve free for 14 days.
(2017)
Alport syndrome: impact of digenic
F. Loop, L. Heidet, E. Timmer, B. Bosch, A. Leinonen, C. Antignac, J. Jefferson, A. Maxwell, L. Monnens, C. Schröder, H. Smeets (2000)
Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation.Kidney international, 58 5
(2021)
Clinical and genetic features of autosomal dominant alport syndrome: A cohort study
E. Groopman, M. Marasà, Sophia Cameron-Christie, S. Petrovski, V. Aggarwal, Hila Milo-Rasouly, Yi-fu Li, Junying Zhang, J. Nestor, P. Krithivasan, Wan Lam, A. Mitrotti, S. Piva, B. Kil, Debanjana Chatterjee, Rachel Reingold, Drew Bradbury, Michael DiVecchia, Holly Snyder, Xueru Mu, Karla Mehl, O. Balderes, D. Fasel, C. Weng, J. Radhakrishnan, P. Canetta, G. Appel, A. Bomback, Wooin Ahn, N. Uy, S. Alam, D. Cohen, R. Crew, G. Dube, Maya Rao, S. Kamalakaran, Brett Copeland, Z. Ren, Joshua Bridgers, C. Malone, C. Mebane, Neha Dagaonkar, B. Fellström, C. Haefliger, S. Mohan, S. Sanna-Cherchi, K. Kiryluk, J. Fleckner, R. March, A. Platt, D. Goldstein, A. Gharavi (2019)
Diagnostic Utility of Exome Sequencing for Kidney DiseaseThe New England Journal of Medicine, 380
A. Gulati, Á. Sevillano, M. Praga, E. Gutiérrez, I. Alba, N. Dahl, Whitney Besse, Jungmin Choi, S. Somlo (2019)
Collagen IV Gene Mutations in Adults With Bilateral Renal Cysts and CKDKidney International Reports, 5
(2014)
membrane nephropathy
C. Fallerini, L. Dosa, R. Tita, D. Prete, S. Feriozzi, G. Gai, M. Clementi, A. Manna, N. Miglietti, R. Mancini, G. Mandrile, G. Ghiggeri, G. Piaggio, F. Brancati, L. Diano, E. Frate, A. Pinciaroli, M. Giani, P. Castorina, E. Bresin, D. Giachino, M. Marchi, F. Mari, M. Bruttini, A. Renieri, F. Ariani (2014)
Unbiased next generation sequencing analysis confirms the existence of autosomal dominant Alport syndrome in a relevant fraction of casesClinical Genetics, 86
(2021)
Prevalence estimates of pre
J. Hoefele, A. Nayır, M. Chaki, A. Imm, Susan Allen, E. Otto, F. Hildebrandt (2011)
Pseudodominant inheritance of nephronophthisis caused by a homozygous NPHP1 deletionPediatric Nephrology, 26
J. Gibson, Rachel Fieldhouse, M. Chan, O. Sadeghi-Alavijeh, L. Burnett, V. Izzi, Anton Persikov, D. Gale, H. Storey, J. Savige (2021)
Prevalence Estimates of Predicted Pathogenic COL4A3–COL4A5 Variants in a Population Sequencing Database and Their Implications for Alport SyndromeJASN, 32
J. Savige, H. Storey, E. Watson, J. Hertz, C. Deltas, A. Renieri, F. Mari, P. Hilbert, P. Plevova, P. Byers, A. Čerkauskaitė, M. Gregory, R. Čerkauskienė, D. Ljubanović, F. Becherucci, C. Errichiello, L. Massella, V. Aiello, R. Lennon, Louise Hopkinson, A. Koziell, A. Lungu, H. Rothe, J. Hoefele, M. Zacchia, T. Martić, Asheeta Gupta, A. Eerde, S. Gear, Samuela Landini, V. Palazzo, Laith Al-Rabadi, K. Claes, A. Corveleyn, Evelien Hoof, M. Geel, Maggie Williams, E. Ashton, Hendica Belge, E. Ars, Agnieszka Bierzynska, C. Gangemi, B. Lipska-Ziętkiewicz (2021)
Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteriaEuropean Journal of Human Genetics, 29
C. Kashtan, Jie Ding, G. Garosi, L. Heidet, L. Massella, K. Nakanishi, K. Nozu, A. Renieri, M. Rheault, F. Wang, O. Gross (2018)
Alport syndrome: a unified classification of genetic disorders of collagen IV α345: a position paper of the Alport Syndrome Classification Working Group.Kidney international, 93 5
D. Gale (2013)
How benign is hematuria? Using genetics to predict prognosisPediatric Nephrology, 28
J. Savige, M. Gregory, O. Gross, C. Kashtan, Jie Ding, F. Flinter (2013)
Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy.Journal of the American Society of Nephrology : JASN, 24 3
(1994)
Complete primary structure of the human Alpha 3(IV) Collagen Chain
J. Savige, D. Colville, M. Rheault, S. Gear, R. Lennon, Sharon Lagas, M. Finlay, F. Flinter (2016)
Alport Syndrome in Women and Girls.Clinical journal of the American Society of Nephrology : CJASN, 11 9
(2022)
Additional supporting information may be found in the online version of the article at the publisher's website. How to cite this article
Gemma Bullich, D. Trujillano, S. Santín, S. Ossowski, S. Mendizábal, G. Fraga, Á. Madrid, G. Ariceta, J. Ballarín, R. Torra, X. Estivill, E. Ars (2014)
Targeted next-generation sequencing in steroid-resistant nephrotic syndrome: mutations in multiple glomerular genes may influence disease severityEuropean Journal of Human Genetics, 23
K. Voskarides, M. Arsali, Y. Athanasiou, A. Elia, A. Pierides, C. Deltas (2012)
Evidence that NPHS2-R229Q predisposes to proteinuria and renal failure in familial hematuriaPediatric Nephrology, 27
(2022)
Pseudodominant Alport syndrome caused by pathogenic homozygous and compound
Andrew Malone, Andrew Malone, P. Phelan, P. Phelan, G. Hall, G. Hall, U. Cetinçelik, Alison Homstad, Alison Homstad, Andrea Alonso, Andrea Alonso, Ruiji Jiang, Ruiji Jiang, Thomas Lindsey, Guanghong Wu, M. Sparks, Stephen Smith, N. Webb, P. Kalra, A. Adeyemo, A. Shaw, P. Conlon, J. Jennette, D. Howell, M. Winn, M. Winn, R. Gbadegesin, R. Gbadegesin (2014)
Rare hereditary COL4A3/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosisKidney international, 86
J. Savige, F. Ariani, F. Mari, M. Bruttini, A. Renieri, O. Gross, C. Deltas, F. Flinter, Jie Ding, D. Gale, M. Nagel, M. Yau, L. Shagam, R. Torra, E. Ars, J. Hoefele, G. Garosi, H. Storey (2018)
Expert consensus guidelines for the genetic diagnosis of Alport syndromePediatric Nephrology, 34
(2019)
Expert Consensus Guidelines
C. Fallerini, M. Baldassarri, E. Trevisson, V. Morbidoni, A. Manna, R. Lazzarin, A. Pasini, G. Barbano, A. Pinciaroli, G. Garosi, E. Frullanti, A. Pinto, M. Mencarelli, F. Mari, A. Renieri, F. Ariani (2017)
Alport syndrome: impact of digenic inheritance in patients managementClinical Genetics, 92
M. Mariyama, A. Leinonen, T. Mochizuki, K. Tryggvason, S. Reeders (1994)
Complete primary structure of the human alpha 3(IV) collagen chain. Coexpression of the alpha 3(IV) and alpha 4(IV) collagen chains in human tissues.The Journal of biological chemistry, 269 37
Alport syndrome is a genetic disorder affecting the basement membranes of the kidney, ear and eye, and represents a leading cause of monogenic kidney disease. Alport syndrome is genetically heterogeneous with three key genes involved (COL4A3‐5) and several transmission patterns, including monogenic X‐linked, autosomal recessive/dominant and digenic. We report a consanguineous family where 13 individuals presented variable features of Alport syndrome including kidney failure on two generations and male‐to‐male transmission, suggesting autosomal dominant inheritance. COL4A3‐5 gene panel analysis surprisingly reveals two distinct, confirmed splice‐altering variants in COL4A3 (NM_000091.4: c.1150+5G>A and c.4028‐3C>T) present in homozygous or compound heterozygous state in individuals with kidney failure. This adds a further mode of transmission for Alport syndrome where, in a consanguineous family, the independent segregation of two variants at the same locus may create a pseudodominant transmission pattern. These findings highlight the importance of a molecular diagnosis in Alport syndrome for genetic risk counselling, given the variable modes of inheritance, but also the pitfalls of assuming identity by descent in consanguineous families.
Annals of Human Genetics – Wiley
Published: May 1, 2022
Keywords: Alport syndrome; COL4A3; chronic kidney disease; genetic counselling; massively parallel sequencing; haematuria
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.